Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 737

2.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
3.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
4.
5.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
6.

Ezetimibe: a novel option for lowering cholesterol.

Davidson MH.

Expert Rev Cardiovasc Ther. 2003 May;1(1):11-21. Review.

PMID:
15030293
7.

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.

Mikhailidis DP, Lawson RW, McCormick AL, Sibbring GC, Tershakovec AM, Davies GM, Tunceli K.

Curr Med Res Opin. 2011 Jun;27(6):1191-210. doi: 10.1185/03007995.2011.571239. Epub 2011 Apr 7. Review.

PMID:
21473671
8.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
9.

Statin and ezetimibe combination therapy in cardiovascular disease.

Dembowski E, Davidson MH.

Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):183-8. doi: 10.1097/MED.0b013e3283295297. Review.

PMID:
19262375
10.

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.

11.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

12.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

13.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

14.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
15.

Effectiveness of statin therapy in adults with coronary heart disease.

Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, Larsen G, McCall A, Pineros S, Sales A.

Arch Intern Med. 2004 Jul 12;164(13):1427-36. Review.

PMID:
15249352
16.

Management of hypercholesterolaemia in postmenopausal women.

Davidson MH, Maki KC, Karp SK, Ingram KA.

Drugs Aging. 2002;19(3):169-78. Review.

PMID:
12027776
17.
18.

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.

Morrone D, Weintraub WS, Toth PP, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM.

Atherosclerosis. 2012 Aug;223(2):251-61. doi: 10.1016/j.atherosclerosis.2012.02.016. Epub 2012 Feb 16. Review.

PMID:
22410123
19.

Ezetimibe.

Darkes MJ, Poole RM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. Review.

PMID:
14727947
20.

The power of statins: aggressive lipid lowering.

Stein EA.

Clin Cardiol. 2003 Apr;26(4 Suppl 3):III25-31. Review.

Supplemental Content

Support Center